Aims: Danon disease is an X-linked dominant lysosomal glycogen storage disorder characterized by cardiomyopathy, skeletal myopathy, and mental retardation. This study described two Chinese cases of Danon disease in order to broaden the phenotypic and genetic spectrum. Methods: Clinical data were collected and LAMP2 mutations were analyzed. Results: Patient A had fluctuating limb weakness during 6 months follow-up and was diagnosed with drug-induced myopathy due to anti-hepatitis B therapy with lamivudine. However, the first muscle biopsy with large cytoplasmic vacuoles confused the diagnosis and led to the second biopsy that allowed for the final diagnosis. Patient B had severe cardiac disturbances leading to sudden death. Molecularly, patient A harbored a synonymous mutation adjacent to the exon 6-intron 6 junction; mRNA analysis provided evidence that totally abolished the donor site and caused skipping of exon 6. Patient B harbored a frame-shift deletion mutation in exon 3 (c.396de1A) leading to a truncated protein. Discussion: To our knowledge, this is the first report of Danon disease caused by a synonymous exon mutation that affected mRNA splicing, which indicates that a synonymous substitution may not be silent when it is in the exon sequences close to the splice sites. It is also the first description of Danon disease clinically presenting as drug-induced myopathy at onset; the pathological changes might be the key point for making a differential diagnosis.
[1]Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China.
[2]Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai 200040, Peoples R China.
[3]Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200040, Peoples R China.
(8.0+极速模式)